Oneness Biotech Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Oneness Biotech Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Oneness Biotech Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Oneness Biotech Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Oneness Biotech Co Ltd (Oneness Biotech) is a biopharmaceutical company that carries out the development of new drugs for unmet medical needs. The company's activities include research and development of innovative pharmaceuticals, in the fields of chronic dermatology and immunology. Its product pipeline comprises ON101 for diabetic foot ulcers; FB825 for atopic dermatitis and allergic asthma; FB704A for severe asthma; OB318 for cancer; and SNS812, for Pan COVID; and SNS851 for weight loss metabolism diseases. Oneness Biotech offers products in the therapeutic areas of dermatology, immunology and infectious diseases, among others. The company operates in Taiwan, Macau, Singapore, Malaysia, China, and Indonesia. Oneness is headquartered in Taipei, Taiwan.
Oneness Biotech Co Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pipeline | FESPIXON |
| ON101: Diabetic Foot Ulcer | Bonvadis |
| FB825: Atopic Dermatitis Allergic Asthma | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Oneness Biotech Co Ltd | Lotus Pharmaceutical Co Ltd | Orient Europharma Co Ltd | Savior Lifetec Corp | Innopharmax Inc |
|---|---|---|---|---|---|
| Headquarters | Taiwan | Taiwan | Taiwan | Taiwan | Taiwan |
| City | Taipei | Taipei | Taipei | Tainan | Taipei |
| State/Province | - | Taipei | - | Taipei | - |
| No. of Employees | 43 | 1,099 | 800 | 319 | 34 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Hsienshou Kuo, PhD | Chairman | Executive Board | - | - |
| Kuo, Hsien-Shou | Chairman | Executive Board | - | - |
| William Lu | Chief Executive Officer | Senior Management | 2021 | - |
| Shuling Cheng, PhD | President | Senior Management | - | - |
| Tingfang Chen | Assistant Vice President - Finance Department | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer